# Calidi (CLDI) — News

CLDI · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/cldi/news

## Recent headlines

- [Calidi Biotherapeutics announces $1.2 million registered direct offering](https://www.ainvest.com/news/calidi-biotherapeutics-announces-1-2-million-registered-direct-offering-2609) — AInvest Wire, Sep 17, 2026
  Calidi Biotherapeutics Inc. (NYSE American: CLDI) has announced a $1.2 million registered direct offering to support its ongoing development of targeted genetic medicines and advance its pipeline toward clinical trials. The offering, which is part of the company’s broader capital-raising strategy,…
- [Calidi: reverse stock split, expected to begin trading on a 1-for-16 split adjusted basis on July 31, 2026](https://www.ainvest.com/news/calidi-reverse-stock-split-expected-trading-1-16-split-adjusted-basis-july-31-2026-2607) — AInvest Wire, Jul 20, 2026
- [Calidi Biotherapeutics appoints former Genentech/Roche and Celgene executive Corsee Sanders, Ph.D., to board of directors](https://www.ainvest.com/news/calidi-biotherapeutics-appoints-genentech-roche-celgene-executive-corsee-sanders-ph-board-directors-2606) — AInvest Wire, Jun 23, 2026
- [Calidi Biotherapeutics - targets CLD-401 regulatory submission by year-end, first-in-human trial in early 2027](https://www.ainvest.com/news/calidi-biotherapeutics-targets-cld-401-regulatory-submission-year-human-trial-early-2027-2606) — AInvest Wire, Jun 16, 2026
- [Calidi Biotherapeutics receives positive pre-IND feedback from US FDA for CLD-401 indicating agreement on its current development strategy as it advances towards a first-in-human study](https://www.ainvest.com/news/calidi-biotherapeutics-receives-positive-pre-ind-feedback-fda-cld-401-indicating-agreement-current-development-strategy-advances-human-study-2606) — AInvest Wire, Jun 16, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).